Skip to main content
SpringerLink
Log in

Fertility

  • Chapter
  • First Online:
Adjuvant Therapy for Breast Cancer

Part of the book series: Cancer Treatment and Research ((CTAR,volume 151))

Abstract

Breast cancer is the most common invasive cancer in women of childbearing age, and the most common cause of cancer-related death in young women. It is estimated that 1 in every 210 women under 40 years old will be diagnosed with breast cancer, and young women represent approximately 5% of new breast cancer patients in the United States [1]. This translates into more than 10,000 women diagnosed annually with breast cancer under age 40 in the United States alone, and over 50,000 young women diagnosed worldwide [1]. Young women with breast cancer face not only the anxieties associated with a potentially life-threatening illness and aggressive treatment, but also several unique medical and psychosocial issues. Future fertility, in particular, has been increasingly recognized as a major concern for many young breast cancer survivors [2, 3].

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 279.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2007. CA Cancer J Clin. 2007;57:43–66.

    Article  PubMed  Google Scholar 

  2. Lee SJ, Schover LR, Partridge AH, et al.American Society of Clinical Oncology Recommendations on Fertility Preservation in Cancer Patients. J Clin Oncol. 2006;24(18):2917–31.

    Google Scholar 

  3. Partridge AH, Gelber S, Peppercorn J, et al. Web-based survey of fertility issues in young women with breast cancer. J Clin Oncol. 2004;22:4174–83.

    Article  PubMed  Google Scholar 

  4. Pagani O, O'Neill A, Castiglione M, et al. Prognostic impact of amenorrhoea after adjuvant chemotherapy in premenopausal breast cancer patients with axillary node involvement: results of the International Breast Cancer Study Group (IBCSG) Trial VI. Eur J Cancer. 1998;34:632–40.

    Article  PubMed  CAS  Google Scholar 

  5. Parulekar WR, Day AG, Ottaway JA, et al. Incidence and prognostic impact of amenorrhea during adjuvant therapy in high-risk premenopausal breast cancer: analysis of a National Cancer Institute of Canada Clinical Trials Group Study--NCIC CTG MA.5. J Clin Oncol. 2005;23:6002–8.

    Article  PubMed  Google Scholar 

  6. Goldhirsch A, Gelber RD, Castiglione M. The magnitude of endocrine effects of adjuvant chemotherapy for premenopausal breast cancer patients. The International Breast Cancer Study Group. Ann Oncol. 1990;1:183–8.

    PubMed  CAS  Google Scholar 

  7. Louis J, Limarzi LR, Best WR. Treatment of chronic granulocytic leukemia with Myleran. Arch Int Med. 1956;97:299–308.

    Article  CAS  Google Scholar 

  8. Falcone T, Attaran M, Bedaiwy MA, et al. Ovarian function preservation in the cancer patient. Fertil Steril. 2004;81:243–57

    Article  PubMed  Google Scholar 

  9. Marhhom E, Cohen I. Fertility preservation options for women with malignancies. Obstet Gynecol Surv. 2007;62:58–72.

    Article  PubMed  Google Scholar 

  10. Di Cosimo S, Alimonti A, Ferretti G, et al. Incidence of chemotherapy-induced amenorrhea depending on the timing of treatment by menstrual cycle phase in women with early breast cancer. Ann Oncol. 2004;15:1065–71.

    Article  PubMed  Google Scholar 

  11. Hrushesky WJ, Vyzula R, Wood PA. Fertility maintenance and 5-fluorouracil timing within the mammalian fertility cycle. Reprod Toxicol. 1999;13:413–20.

    Article  PubMed  CAS  Google Scholar 

  12. Mehta RR, Beattie CW, Das Gupta TK. Endocrine profile in breast cancer patients receiving chemotherapy. Breast Cancer Res Treat. 1992;20:125–32

    Article  PubMed  CAS  Google Scholar 

  13. Walshe JM, Denduluri N, Swain SM. Amenorrhea in premenopausal women after adjuvant chemotherapy for breast cancer. J Clin Oncol. 2006;24:5769–79.

    Article  PubMed  CAS  Google Scholar 

  14. Petrek JA, Naughton MJ, Case LD, et al. Incidence, time course, and determinants of menstrual bleeding after breast cancer treatment: A prospective study. J Clin Oncol. 2006;24:1045–51.

    Article  PubMed  Google Scholar 

  15. Bines J, Oleske DM, Cobleigh MA. Ovarian function in premenopausal women treated with adjuvant chemotherapy for breast cancer. J Clin Oncol. 1996;14:1718–29.

    PubMed  CAS  Google Scholar 

  16. Anderson RA, Themmen AP, Al-Qahtani A, et al. The effects of chemotherapy and long-term gonadotrophin suppression on the ovarian reserve in premenopausal women with breast cancer. Hum Reprod. 2006;21:2583–92.

    Article  PubMed  CAS  Google Scholar 

  17. Kramer R, Tham YL, Sexton K, et al. Chemotherapy-induced amenorrhea is increased in patients treated wtih adjuvant doxorubicin and cyclophosphamide (AC) followed by a taxane (T). J Clin Oncol, ASCO Annual Meeting Proceedings 2005;23:651.

    Google Scholar 

  18. Fornier MN, Modi S, Panageas KS, et al. Incidence of chemotherapy-induced, long-term amenorrhea in patients with breast carcinoma age 40 years and younger after adjuvant anthracycline and taxane. Cancer. 2005;104:1575–9.

    Article  PubMed  CAS  Google Scholar 

  19. Abusief ME, Missmer SA, Ginsburg ES, et al. Chemotherapy-related amenorrhea in women with early breast cancer: The effect of paclitaxel or dose density. Journal of Clinical Oncology, ASCO Annual Meeting Proceedings (Post-Meeting Edition). 2006;24:10506.

    Google Scholar 

  20. Byrne J, Fears TR, Gail MH, et al. Early menopause in long-term survivors of cancer during adolescence. Am J Obstet Gynecol. 1992;166:788–93.

    PubMed  CAS  Google Scholar 

  21. Chiarelli AM, Marrett LD, Darlington G. Early menopause and infertility in females after treatment for childhood cancer diagnosed in 1964–1988 in Ontario, Canada. Am J Epidemiol. 1999;150:245–54.

    PubMed  CAS  Google Scholar 

  22. Sklar CA, Mertens AC, Mitby P, et al. Premature menopause in survivors of childhood cancer: A report from the childhood cancer survivor study. J Natl Cancer Inst. 2006;98:890–6.

    Google Scholar 

  23. Partridge A, Gelber S, Gelber R, et al. Delayed premature menopause following chemotherapy for early stage breast cancer: Long-term results from IBCSG Trial V. Proc Am Soc Clin Oncol. 2005;23:50s (abstract 687)

    Google Scholar 

  24. Partridge A, Gelber S, Gelber R, et al. Age of menopause among women who remain premenopausal following treatment for early breast cancer: long-term results from International Breast Cancer Study Group Trials V and VI. Eur J Cancer. In press

    Google Scholar 

  25. Goodwin PJ, Ennis M, Pritchard KI, et al. Risk of menopause during the first year after breast cancer diagnosis. J Clin Oncol. 1999;17:2365–70.

    PubMed  CAS  Google Scholar 

  26. Weghofer A, Margreiter M, Fauster Y, et al. Age-specific FSH levels as a tool for appropriate patient counselling in assisted reproduction. Hum Reprod. 1005;20:2448.–52

    Google Scholar 

  27. Bath LE, Tydeman G, Critchley HOD, et al. Spontaneous conception in a young woman who had ovarian cortical tissue cryopreservation before chemotherapy and radiotherapy for a Ewing's sarcoma of the pelvis: Case report. Hum Reprod. 2004;19:2569–72.

    Google Scholar 

  28. Blumenfeld Z, Ritter M, Shen-Orr Z, et al. Inhibin A concentrations in the sera of young women during and after chemotherapy for lymphoma: Correlation with ovarian toxicity. Am J Reprod Immunol. 1998;39:33–40

    Article  PubMed  CAS  Google Scholar 

  29. Blumenfeld Z. Preservation of fertility and ovarian function and minimalization of chemotherapy associated gonadotoxicity and premature ovarian failure: The role of inhibin-A and -B as markers. Mol Cell Endocrinol. 2002;187:93–105.

    Article  PubMed  CAS  Google Scholar 

  30. van Rooij IA, Broekmans FJ, te Velde ER, et al. Serum anti-Mullerian hormone levels: A novel measure of ovarian reserve. Hum Reprod. 2002;17:3065–71

    Article  PubMed  Google Scholar 

  31. Scheffer GJ, Broekmans FJ, Looman CW, et al. The number of antral follicles in normal women with proven fertility is the best reflection of reproductive age. Hum Reprod. 2003;18:700–6.

    Article  PubMed  CAS  Google Scholar 

  32. Schmidt KL, Byskov AG, Nyboe Andersen A, et al. Density and distribution of primordial follicles in single pieces of cortex from 21 patients and in individual pieces of cortex from three entire human ovaries. Hum Reprod. 2003;18:1158–64.

    Article  PubMed  CAS  Google Scholar 

  33. Cook CL, Siow Y, Taylor S, et al. Serum mullerian-inhibiting substance levels during normal menstrual cycles. Fertil Steril. 2000;73:859–61.

    Article  PubMed  CAS  Google Scholar 

  34. Whitehead E, Shalet SM, Blackledge G, et al. The effect of combination chemotherapy on ovarian function in women treated for Hodgkin's disease. Cancer. 1983;52:988–93.

    Article  PubMed  CAS  Google Scholar 

  35. Behringer K, Breuer K, Reineke T, et al. Secondary amenorrhea after Hodgkin's lymphoma is influenced by age at treatment, stage of disease, chemotherapy regimen, and the use of oral contraceptives during therapy: A report from the German Hodgkin's Lymphoma Study Group. J Clin Oncol. 2005;23:7555–64.

    Google Scholar 

  36. Ataya K, Rao LV, Lawrence E, et al. Luteinizing hormone-releasing hormone agonist inhibits cyclophosphamide-induced ovarian follicular depletion in rhesus monkeys. Biol Reprod. 1995;52:365–72.

    Article  PubMed  CAS  Google Scholar 

  37. Letterie GS. Anovulation in the prevention of cytotoxic-induced follicular attrition and ovarian failure. Hum Reprod. 2004;19:831–7.

    Article  PubMed  CAS  Google Scholar 

  38. Grundker C, Emons G. Role of gonadotropin-releasing hormone (GnRH) in ovarian cancer. Reprod Biol Endocrinol. 2003;1:65.

    Article  PubMed  Google Scholar 

  39. Waxman JH, Ahmed R, Smith D, et al. Failure to preserve fertility in patients with Hodgkin's disease. Cancer Chemother Pharmacol. 1987;19:159–62

    Article  PubMed  CAS  Google Scholar 

  40. Dann EJ, Epelbaum R, Avivi I, et al. Fertility and ovarian function are preserved in women treated with an intensified regimen of cyclophosphamide, adriamycin, vincristine and prednisone (Mega-CHOP) for non-Hodgkin lymphoma. Hum Reprod. 2005;20:2247–9.

    Article  PubMed  CAS  Google Scholar 

  41. Blumenfeld Z, Eckman A. Preservation of fertility and ovarian function and minimization of chemotherapy-induced gonadotoxicity in young women by GnRH-a. J Natl Cancer Inst Monogr. 2005;40–3

    Google Scholar 

  42. Pereyra Pacheco B, Mendez Ribas JM, Milone G, et al. Use of GnRH analogs for functional protection of the ovary and preservation of fertility during cancer treatment in adolescents: A preliminary report. Gynecol Oncol. 2001;81:391–7

    Google Scholar 

  43. Recchia F, Sica G, De Filippis S, et al. Goserelin as ovarian protection in the adjuvant treatment of premenopausal breast cancer: A phase II pilot study. Anticancer Drugs. 2002;13:417–24.

    Article  PubMed  CAS  Google Scholar 

  44. Fox KR, Scialla J, Moore H. Preventing chemotherapy-related amenorrhea using leuprolide during adjuvant chemotherapy for early-stage breast cancer [abstract 50]. Proc ASCO. 2003;22:13.

    Google Scholar 

  45. Danforth DR, Arbogast LK, Friedman CI. Acute depletion of murine primordial follicle reserve by gonadotropin-releasing hormone antagonists. Fertil Steril. 2005;83:1333–8

    Article  PubMed  CAS  Google Scholar 

  46. Meirow D, Assad G, Dor J, et al. The GnRH antagonist cetrorelix reduces cyclophosphamide-induced ovarian follicular destruction in mice. Hum Reprod. 2004;19:1294–9.

    Article  PubMed  CAS  Google Scholar 

  47. Morita Y, Perez GI, Paris F, et al. Oocyte apoptosis is suppressed by disruption of the acid sphingomyelinase gene or by sphingosine-1-phosphate therapy. Nat Med. 2000;6:1109–14.

    Article  PubMed  CAS  Google Scholar 

  48. Pal L, Leykin L, Schifren JL, et al. Malignancy may adversely influence the quality and behaviour of oocytes. Hum Reprod. 1998;13:1837–40.

    Article  PubMed  CAS  Google Scholar 

  49. Oktay K, Buyuk E, Davis O, et al. Fertility preservation in breast cancer patients: IVF and embryo cryopreservation after ovarian stimulation with tamoxifen. Hum Reprod. 2003;18:90–5.

    Article  PubMed  CAS  Google Scholar 

  50. Mitwally MF, Casper RF. Single-dose administration of an aromatase inhibitor for ovarian stimulation. Fertil Steril. 2005;83:229–31.

    Article  PubMed  CAS  Google Scholar 

  51. Oktay K, Buyuk E, Libertella N, et al. Fertility preservation in breast cancer patients: A prospective controlled comparison of ovarian stimulation with tamoxifen and letrozole for embryo cryopreservation. J Clin Oncol. 2005;23:4347–53.

    Article  PubMed  CAS  Google Scholar 

  52. Kim SS, Radford J, Harris M, et al. Ovarian tissue harvested from lymphoma patients to preserve fertility may be safe for autotransplantation. Hum Reprod. 2001;16:2056–60.

    Article  PubMed  CAS  Google Scholar 

  53. Donnez J, Dolmans MM, Demylle D, et al. Restoration of ovarian function after orthotopic (intraovarian and periovarian) transplantation of cryopreserved ovarian tissue in a woman treated by bone marrow transplantation for sickle cell anaemia: case report. Hum Reprod. 2006:21:183–8.

    Google Scholar 

  54. Donnez J, Dolmans MM, Demylle D, et al. Livebirth after orthotopic transplantation of cryopreserved ovarian tissue. Lancet. 2004;364:1405–10.

    Article  PubMed  CAS  Google Scholar 

  55. Partridge A, Gelber S, Peppercorn J, et al. Fertility outcomes in young women with breast cancer: A web-based survey. Proc ASCO. 2004;23:538 [abstract #6085].

    Google Scholar 

  56. Ives A, Saunders C, Bulsara M, et al. Pregnancy after breast cancer: Population based study. BMJ.2007;334:194.

    Article  PubMed  Google Scholar 

  57. Hawkins MM. Pregnancy outcome and offspring after childhood cancer. BMJ. 1994;309:1034.

    Article  PubMed  CAS  Google Scholar 

  58. Kroman N, Jensen MB, Melbye M, et al. Should women be advised against pregnancy after breast-cancer treatment? Lancet. 1997;350:319–22.

    Article  PubMed  CAS  Google Scholar 

  59. Sankila R, Heinavaara S, Hakulinen T. Survival of breast cancer patients after subsequent term pregnancy: “Healthy mother effect”. Am J Obstet Gynecol. 1994;170:818–23.

    PubMed  CAS  Google Scholar 

  60. von Schoultz E, Johansson H, Wilking N, et al. Influence of prior and subsequent pregnancy on breast cancer prognosis. J Clin Oncol. 1995;13:430–4.

    Google Scholar 

  61. Petrek JA. Pregnancy safety after breast cancer. Cancer. 1994;74:528–31.

    Article  PubMed  CAS  Google Scholar 

  62. Gemignani ML, Petrek JA. Pregnancy After Breast Cancer. Cancer Control. 1999;6:272–6.

    PubMed  Google Scholar 

  63. Velentgas P, Daling JR, Malone KE, et al. Pregnancy after breast carcinoma: Outcomes and Influence on Mortality. Cancer. 1999;85:2424–32.

    Article  PubMed  CAS  Google Scholar 

  64. Dow KH. Having children after breast cancer. Cancer Pract. 1994;2:407–13.

    PubMed  CAS  Google Scholar 

  65. Higgins S, Haffty BG. Pregnancy and lactation after breast-conserving therapy for early stage breast cancer. Cancer. 1994;73:2175–80.

    Article  PubMed  CAS  Google Scholar 

  66. Gelber S, Coates AS, Goldhirsch A, et al. Effect of pregnancy on overall survival after the diagnosis of early-stage breast cancer. J Clin Oncol. 2001;19:1671–5.

    PubMed  CAS  Google Scholar 

  67. Upponi SS, Ahmad F, Whitaker IS, et al. Pregnancy after breast cancer. Eur J Cancer. 2003;39:736–41.

    Article  PubMed  CAS  Google Scholar 

  68. Mueller BA, Simon MS, Deapen D, et al. Childbearing and survival after breast carcinoma in young women. Cancer. 2003;98:1131–40.

    Article  PubMed  Google Scholar 

  69. Blakely LJ, Buzdar AU, Lozada JA, et al. Effects of pregnancy after treatment for breast carcinoma on survival and risk of recurrence. Cancer. 2004;100:465–9.

    Article  PubMed  Google Scholar 

  70. Sankila R, Heinavaara S, Hakulinen T. Survival of breast cancer patients after subsequent term pregnancy: “Healthy mother effect”. Am J Obstet Gynecol. 1994;170:818–23.

    PubMed  CAS  Google Scholar 

  71. Yuri T, Tsukamoto R, Miki K, et al. Biphasic effects of zeranol on the growth of estrogen receptor-positive human breast carcinoma cells. Oncol Rep. 2006;16:1307–12.

    PubMed  CAS  Google Scholar 

  72. Duffy CM, Allen SM, Clark MA. Discussions regarding reproductive health for young women with breast cancer undergoing chemotherapy. J Clin Oncol. 2005;23:766–73.

    Article  PubMed  Google Scholar 

  73. Thewes B, Meiser B, Taylor A, et al. Fertility- and menopause-related information needs of younger women with a diagnosis of early breast cancer. J Clin Oncol. 2005;23:5155–65.

    Article  PubMed  CAS  Google Scholar 

  74. Burstein HJ, Winer EP. Primary care for survivors of breast cancer. N Engl J Med. 2000;343:1086–94.

    Article  PubMed  CAS  Google Scholar 

  75. Martin M, Pienkowski T, Mackey J, et al. Adjuvant docetaxel for node-positive breast cancer. N Engl J Med. 2005;352:2302–13.

    Article  PubMed  CAS  Google Scholar 

  76. Castelo-Branco C, Nomdedeu B, Camus A, et al. Use of gonadotropin-releasing hormone agonists in patients with Hodgkin's disease for preservation of ovarian function and reduction of gonadotoxicity related to chemotherapy. Fertil Steril. 2007;87:702–5.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Brigham and Women’s Hospital, Harvard Medical School, Dana-Farber Cancer Institute, Boston, MA, USA

    K. J. Ruddy

  2. Dana-Farber Cancer Institute, 44 Binney St., 02115, Boston, MA, USA

    A. H. Partridge

Authors
  1. K. J. Ruddy
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. A. H. Partridge
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to A. H. Partridge .

Editor information

Editors and Affiliations

  1. Inselspital, Univ. Bern, Bern, 3010, Switzerland

    Monica Castiglione

  2. Inst. Jules Bordet, Universite Libre Bruxelles, Bd. de Waterloo 125, Bruxelles, 1000, Belgium

    Martine J. Piccart

Rights and permissions

Reprints and permissions

Copyright information

© 2009 Springer Science+Business Media, LLC

About this chapter

Cite this chapter

Ruddy, K.J., Partridge, A.H. (2009). Fertility. In: Castiglione, M., Piccart, M. (eds) Adjuvant Therapy for Breast Cancer. Cancer Treatment and Research, vol 151. Springer, Boston, MA. https://doi.org/10.1007/978-0-387-75115-3_23

Download citation

  • DOI: https://doi.org/10.1007/978-0-387-75115-3_23

  • Published:

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-0-387-75114-6

  • Online ISBN: 978-0-387-75115-3

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation